daunorubicin has been researched along with Genetic Predisposition in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Arber, DA; Erba, HP | 1 |
| Adly, AAM; Ebeid, FSE; El-Ghoroury, E; Mostafa, M; Tantawy, AAG | 1 |
| Gou, H; Hu, X; Lu, X; Peng, W; Shang, M; Song, X; Ye, Y; Ying, B; Zhang, J; Zhao, Z; Zhou, J; Zhou, Y | 1 |
| Beltrão, EI; Benicio, MT; Bezerra, MA; Bezerra, MF; Coelho-Silva, JL; Lucena-Araujo, AR; Machado, CG; Nascimento, JC; Rego, EM; Rocha, CR | 1 |
| Abdulghaffar, EE; Abou El Asrar, M; Adly, AA; El-Bostany, EA; El-Ghouroury, EA; Tantawy, AA | 1 |
| Dhall, G; Ettinger, LJ; Lastra, C; Mahadeo, KM; Panigrahy, A | 1 |
| Gietema, JA; Postma, A; van den Berg, MP; van Spaendonck-Zwarts, KY; van Tintelen, JP; van Veldhuisen, DJ | 1 |
| Cox, NJ; Dolan, ME; Gamazon, ER; Huang, RS | 1 |
| Bruyere, H; Copland, M; Hogge, DE; Horsman, DE; Lavoie, JC; Le, A; Nantel, SH; Nevill, TJ; Seftel, MD; Shepherd, JD; Sutherland, HJ; Toze, CL | 1 |
| Allen, SL; Archer, KJ; Baldus, CD; Bloomfield, CD; Caligiuri, MA; Carroll, AJ; de la Chapelle, A; Kolitz, JE; Larson, RA; Marcucci, G; Moore, JO; Powell, BL; Ruppert, AS; Tanner, SM; Vardiman, JW; Whitman, SP | 1 |
| den Boer, ML; Hall, AG; Irving, JA; Janka-Schaub, GE; Meier, M; Minto, L; Passier, M; Pieters, R; van Wering, ER | 1 |
| Gratwohl, A; Rimner, T; Tichelli, A; Went, P | 1 |
| Buck, SA; Chen, Q; Diakiw, AE; Dombkowski, AA; Ge, Y; LaFiura, KM; Matherly, LH; Payton, SG; Salagrama, S; Taub, JW | 1 |
| Bleibel, WK; Das, S; Delaney, SM; Dolan, ME; Duan, S; Fackenthal, DL; Huang, RS; Kistner, EO | 1 |
| Hishida, A; Honda, N; Kimura, M; Nishimura, M; Ohtake, T; Sato, T; Takahasi, H | 1 |
| Lange, B | 1 |
| Blazek, B; Gajdos, P; Hak, J; Hrstkova, H; Jabali, Y; Mihál, V; Mydlil, J; Starý, J; Timr, P | 1 |
2 review(s) available for daunorubicin and Genetic Predisposition
| Article | Year |
|---|---|
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC).
Topics: Aged; Aminopyridines; Antineoplastic Agents; Blood Cells; Bone Marrow; Bone Marrow Examination; Chromosome Aberrations; Cytarabine; Cytogenetic Analysis; Daunorubicin; DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Prognosis; PubMed; Triazines | 2020 |
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Down Syndrome; Female; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Leukemia; Leukemia, Myeloid; Male; Maternal Age; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine | 2000 |
1 trial(s) available for daunorubicin and Genetic Predisposition
| Article | Year |
|---|---|
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Genetic Markers; Genetic Predisposition to Disease; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Treatment Outcome | 2003 |
14 other study(ies) available for daunorubicin and Genetic Predisposition
| Article | Year |
|---|---|
Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.
Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Infant; Male; Mercaptopurine; Methyltransferases; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 2017 |
The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Proteins; China; Cytarabine; Daunorubicin; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Mutational Analysis; Female; fms-Like Tyrosine Kinase 3; Gene Frequency; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Proteins; Nuclear Proteins; Nucleophosmin; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-kit; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Survival Analysis; Thioguanine; Tumor Suppressor Protein p53 | 2017 |
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Egypt; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Mercaptopurine; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasm Proteins; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Stomatitis; Vincristine | 2010 |
Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct end
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Daunorubicin; Endothelium, Vascular; Epilepsy, Tonic-Clonic; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Injections, Spinal; Leukoencephalopathies; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Sinus Thrombosis, Intracranial; Vincristine | 2010 |
Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
Topics: Adult; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathy, Dilated; Cardiotoxins; Daunorubicin; Doxorubicin; Genetic Predisposition to Disease; Humans; Male; Neoplasms; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Copy number polymorphisms and anticancer pharmacogenomics.
Topics: Antineoplastic Agents; Biomarkers, Pharmacological; Carboplatin; Cell Line, Tumor; Cisplatin; Daunorubicin; Etoposide; Gene Dosage; Gene Expression; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genome, Human; Humans; Inhibitory Concentration 50; Neoplasms; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Topoisomerase II Inhibitors | 2011 |
Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).
Topics: Adolescent; Adult; Antineoplastic Agents; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Daunorubicin; Female; Genetic Predisposition to Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Tumor Lysis Syndrome | 2002 |
Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Ataxia Telangiectasia Mutated Proteins; Case-Control Studies; Cell Cycle Proteins; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Genetic Predisposition to Disease; Humans; Infant; Leukemia-Lymphoma, Adult T-Cell; Leukocyte Count; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Prognosis; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Tumor Suppressor Proteins | 2005 |
Concomitant hairy cell and acute myeloid leukemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Daunorubicin; Genetic Predisposition to Disease; Humans; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Stem Cell Transplantation | 2006 |
The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.
Topics: Acute Disease; Cell Differentiation; Child; Chromosomes, Human, Pair 21; Cytarabine; Daunorubicin; Down Syndrome; Drug Resistance, Neoplasm; Erythroid Precursor Cells; Erythropoiesis; GATA1 Transcription Factor; Gene Dosage; Gene Expression Regulation, Leukemic; Genetic Predisposition to Disease; Humans; K562 Cells; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Megakaryocytes; Neoplasm Proteins; Proto-Oncogene Mas; Proto-Oncogene Protein c-ets-2; Thrombopoiesis | 2008 |
Genetic variants contributing to daunorubicin-induced cytotoxicity.
Topics: Antibiotics, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Cell Line, Tumor; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme System; Daunorubicin; Drug Resistance, Neoplasm; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Inhibitory Concentration 50; Neoplasms; Polymorphism, Single Nucleotide | 2008 |
Interstrain differences in murine daunomycin-induced nephrosis.
Topics: Albuminuria; Animals; Complement C5; Daunorubicin; Disease Models, Animal; DNA; Genes, MHC Class I; Genes, Recessive; Genetic Predisposition to Disease; Hair Color; Incidence; Major Histocompatibility Complex; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Multigene Family; Nephritis; Species Specificity | 1993 |
Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Human, Pair 11; Czech Republic; Daunorubicin; Diploidy; Disease-Free Survival; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Histone-Lysine N-Methyltransferase; Humans; Infant; Infant, Newborn; Male; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Proto-Oncogenes; Risk Factors; Transcription Factors; Translocation, Genetic; Vincristine | 2000 |